MSTN rs1805086: Understanding the Myostatin K153R Variant
The rs1805086 variant, also known as the K153R polymorphism, occurs in the MSTN gene, which encodes myostatin, a protein that acts as a negative regulator of muscle growth. This variant has been studied for its potential associations with muscle hypertrophy, strength capacity, and the body's response to resistance training.
What each genotype means
Typical myostatin profile
This is the most common genotype for this variant, often referred to as the Lys153 (K) allele. Research into this specific variant is limited, and while some studies suggest the alternative R allele may influence muscle power, this genotype is generally considered the baseline for comparison in population studies.
This is the most prevalent genotype in most global populations, particularly in European and East Asian ancestries.
Heterozygous myostatin variant
You carry one copy of the A allele and one copy of the G allele, also known as the Lys153Arg (K153R) polymorphism. Some research has investigated whether this variant influences muscle power or hypertrophic response to training, but findings are mixed and evidence remains limited regarding its practical impact on athletic performance.
Carried by a small percentage of individuals in European populations, with higher frequencies observed in populations of African descent.
Homozygous myostatin variant
You carry two copies of the G allele, which results in the Arg153 (R) variant of the myostatin protein. While some literature suggests this variant may be associated with differences in muscle power or muscle mass preservation, the evidence is not definitive and results vary significantly across different studies and athletic cohorts.
This genotype is rare in most populations, occurring at a low frequency in Europeans and more frequently in populations of African descent.
What is the rs1805086 Variant?
The rs1805086 variant is a single nucleotide polymorphism (SNP) located within the MSTN gene on chromosome 2. Specifically, it represents a change in the DNA sequence where an adenine (A) is replaced by a guanine (G). This genetic alteration results in a change at the protein level, where the amino acid lysine (K) is substituted with arginine (R) at position 153 of the myostatin protein. Because this change occurs in a gene responsible for regulating muscle mass, researchers have long been interested in whether this specific substitution alters the protein's function. While the variant is well-documented in genetic databases, it is important to note that it is just one of many factors that influence human physical traits. Genetic variations like rs1805086 are common in the human genome, and their presence does not guarantee any specific physical outcome, as muscle development is a complex process influenced by a combination of genetics, nutrition, and physical activity.
The Role of the MSTN Gene
The MSTN gene provides instructions for making a protein called myostatin. Myostatin is a member of the transforming growth factor-beta (TGF-beta) superfamily and is expressed primarily in skeletal muscle cells. Its primary biological function is to act as a 'brake' on muscle growth, preventing muscles from growing too large. In various mammalian species, loss-of-function mutations in the MSTN gene have been shown to lead to a significant increase in muscle mass and a decrease in body fat. In humans, while complete loss-of-function mutations are rare and can lead to profound muscle hypertrophy, the rs1805086 polymorphism is a much more subtle variation. Scientists study this variant to see if the K153R substitution might slightly modulate the 'braking' effect of myostatin, potentially influencing how an individual's muscles respond to the stress of strength training or their baseline power capacity.
Research and Evidence Strength
The evidence linking rs1805086 to athletic performance and muscle phenotypes is currently considered limited and sometimes conflicting. Some studies have suggested that the rare R allele might be more frequent in strength-oriented athletes, leading to hypotheses that it could enhance the hypertrophic response to training. However, other large-scale meta-analyses have concluded that there is not enough reliable data to definitively label this variant as a primary driver of athletic success. Results often vary based on the ethnicity and gender of the study participants, and many studies have failed to find a statistically significant correlation between the genotype and muscle mass gains. Because of these mixed findings, the scientific community remains cautious. It is essential to view this variant as a subject of ongoing research rather than a proven predictor of physical potential. The complexity of human physiology means that thousands of genes, along with environmental factors, contribute to muscle development.
What You Can and Cannot Do With This Information
If you have access to your genetic data regarding rs1805086, it is important to understand that this information is for educational purposes only. You cannot use this genotype to predict your athletic potential, diagnose a medical condition, or determine your response to specific exercise programs. Genetic testing for this variant is not a substitute for professional guidance from a coach, trainer, or medical professional. If you are interested in optimizing your physical fitness, focus on evidence-based practices such as progressive resistance training, adequate protein intake, and sufficient recovery, which are known to have a much larger impact on muscle growth than any single SNP. If you have concerns about your muscle health or physical development, consult with a healthcare provider. Never use genetic information to make medical decisions or to alter your health regimen without professional clinical advice.
How common is this variant?
The minor allele (G/Arg) frequency is approximately 0.02-0.04 in European populations and is observed at a higher frequency in populations of African descent, typically around 0.15.
Frequently asked questions
Does the rs1805086 variant make me a better athlete?
No. While some studies have explored associations between this variant and strength, the evidence is limited and inconsistent. Athletic performance is determined by a vast array of genetic, environmental, and training factors.
Can I use this SNP to predict my muscle growth?
No. Genetic variants like rs1805086 have a very small, if any, measurable effect on muscle growth. Your training intensity, nutrition, and recovery habits are far more significant factors.
Is the R allele considered a 'mutation'?
In genetics, the term 'variant' or 'polymorphism' is often used for common changes like this. While it is a change from the most common sequence, it is a natural variation found in the human population.
Should I get tested for the MSTN gene?
There is no clinical utility for testing this specific SNP for the general public. If you have concerns about muscle development or health, you should consult a physician rather than relying on direct-to-consumer genetic reports.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1805086?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MSTN
A missense variant (Lys153Arg) in the myostatin gene that modulates negative regulation of skeletal muscle mass and has been correlated with individual differences in muscle volume and resistance training-induced strength gains.
This myostatin variant is overrepresented in elite athlete cohorts, suggesting a potential role in physical performance.